Aberdeen Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.1M | Sell |
139,606
-32,125
| -19% | -$5.54M | 0.04% | 357 |
|
|
2025
Q1 | $26.8M | Sell |
171,731
-15,449
| -8% | -$2.41M | 0.05% | 314 |
|
|
2024
Q4 | $25.8M | Buy |
187,180
+28,967
| +18% | +$3.99M | 0.05% | 318 |
|
|
2024
Q3 | $23.6M | Sell |
158,213
-2,389
| -1% | -$357K | 0.04% | 351 |
|
|
2024
Q2 | $21.9M | Buy |
160,602
+21,811
| +16% | +$2.97M | 0.04% | 362 |
|
|
2024
Q1 | $21M | Hold |
138,791
| – | – | 0.04% | 396 |
|
|
2023
Q4 | $17.5M | Buy |
+138,791
| New | +$17.5M | 0.04% | 421 |
|